[Dose-adjusted EPOCH/EDOCH plus rituximab in untreated double-protein expression lymphoma]

Zhonghua Xue Ye Xue Za Zhi. 2017 Jun 14;38(6):548-551. doi: 10.3760/cma.j.issn.0253-2727.2017.06.017.
[Article in Chinese]
No abstract available

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols
  • Cyclophosphamide
  • Doxorubicin
  • Etoposide
  • Humans
  • Lymphoma*
  • Prednisone
  • Rituximab
  • Vincristine

Substances

  • Rituximab
  • Vincristine
  • Etoposide
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • EPOCH protocol

Grants and funding

基金项目：国家科技支撑计划（2014BAI09B12）；国家自然科学基金（81370632、81200395）